ArticleWorld journal of surgical oncology2018

Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.

Tommi Järvinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.